Basics Celcuity Inc. Common Stock Celcuity Inc is a cellular analysis company. The company is discovering new cancer sub-types and commercializing diagnostic tests. IPO Date: September 20, 2017 Sector: Healthcare Industry: Medical Diagnostics and Research Market Cap: $3.93B Activated in VL: True Average Daily Range Avg Daily Range: $0.48 | 2.98% Avg Daily Range (30 D): $2.41 | 3.55% Avg Daily Range (90 D): $1.82 | 3.35% Institutional Daily Volume Avg Daily Volume: .12M Avg Daily Volume (30 D): 1.11M Avg Daily Volume (90 D): 1.22M Trade Size Avg Trade Size (Sh.): 66 Avg Trade Size (Sh.) (30 D): 55 Avg Trade Size (Sh.) (90 D): 58 Institutional Trades Total Inst.Trades: 686 Avg Inst. Trade: $2.58M Avg Inst. Trade (30 D): $2.86M Avg Inst. Trade (90 D): $2.83M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.78M Avg Closing Trade (30 D): $5.79M Avg Closing Trade (90 D): $5.19M Avg Closing Volume: 126.25K     News Oct 18, 2025 @ 8:30 AM Detailed Results from PIK3CA Wild-Type Cohort o... Source: Celcuity Inc. Oct 18, 2025 @ 8:30 AM Celcuity Presents Updated Data at the 2025 ESMO Co... Source: Celcuity Inc. Oct 18, 2025 @ 8:30 AM Celcuity Provides Update on Status of the PIK3CA M... Source: Brian Sullivan Jul 29, 2025 @ 7:46 PM Biotech Underdogs Line Up for Pivotal Shots at Gam... Source: Prnewswire Jul 8, 2025 @ 2:25 PM Amid NCI Budget Fears, Emerging Oncology Stocks Ga... Source: Prnewswire Financials   TTM Q3 2025 Q2 2025 Basic EPS $-3.69 $-.92 $-1.04 Diluted EPS $-3.69 $-.92 $-1.04 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -162.72M $ -43.8M $ -45.27M Operating Income / Loss $ -159.42M $ -42.85M $ -44.01M Cost of Revenue $ $ $ Net Cash Flow $ 61.65M $ 27.9M $ 29.88M PE Ratio